Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9418812 | 0.87 | ALDH1A1 (0.31) | ALDH1A1TSHRTDP1MEN1CYP1A2 | |
| SCHEMBL29148890 | 0.85 | — | — | |
| SCHEMBL13292154 | 0.82 | TDP1 (0.35) | ALDH1A1TSHRTDP1MEN1KMT2A | |
| SCHEMBL11176953 | 0.79 | LMNA (0.34) | ALDH1A1FFAR3MEN1CYP1A2THRB | |
| SCHEMBL28265919 | 0.79 | CES2 (0.40) | ALDH1A1TSHRTDP1MEN1KMT2A | |
| SCHEMBL5176561 | 0.78 | ALDH1A1 (0.33) | ALDH1A1TSHRFFAR3MEN1CYP1A2 | |
| SCHEMBL27727172 | 0.78 | TSHR (0.36) | ALDH1A1TSHRFFAR3MEN1CYP1A2 | |
| SCHEMBL29048958 | 0.76 | TDP1 (0.33) | ALDH1A1TSHRTDP1FFAR3 | |
| SCHEMBL20865671 | 0.76 | ALOX15 (0.36) | ALDH1A1TSHRTDP1 | |
| SCHEMBL347366 | 0.76 | CYP2C19 (0.46) | ALDH1A1TSHRTDP1FFAR3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109563106-B | Silver ion carboxylate alkyl primary amine complexes | 柯达公司 | 2021-07-27 | — | — | CN | claimed |
| CN-109562628-B | Silver ion carboxylate N-heteroaromatic complex and use | 柯达公司 | 2021-07-27 | — | — | CN | claimed |
| EP-3496951-B1 | SILVER ION CARBOXYLATE N-HETEROAROMATIC COMPLEXES AND USES | EASTMAN KODAK CO (US) | 2021-06-23 | — | — | EP | claimed |
| US-11037692-B2 | Articles having silver ion α-oxy carboxylate oxime complexes | EASTMAN KODAK COMPANY (US) | 2021-06-15 | — | — | US | claimed |
| US-20200048479-A1 | PHOTOSENSITIVE COMPOSITIONS CONTAINING SILVER ION A-OXY CARBOXYLATE-OXIME COMPLEXES | BANK OF AMERICA, N.A., AS AGENT | 2020-02-13 | — | — | US | claimed |
| US-10487221-B2 | Photosensitive compositions containing silver ion α-oxy carboxylate-oxime complexes | EASTMAN KODAK COMPANY (US) | 2019-11-26 | — | — | US | claimed |
| EP-3548498-A1 | SILVER ION ALPHA-OXY CARBOXYLATE-OXIME COMPLEXES FOR PHOTOLITHOGRAPHIC PROCESSES TO GENERATE ELECTRICALLY CONDUCTING METALLIC STRUCTURES | Eastman Kodak Company (US) | 2019-10-09 | — | — | EP | claimed |
| US-10366800-B2 | Methods of providing electrically-conductive silver | EASTMAN KODAK COMPANY (US) | 2019-07-30 | — | — | US | claimed |
| US-20190228873-A1 | ARTICLES HAVING SILVER ION a-OXY CARBOXYLATE OXIME COMPLEXES | BANK OF AMERICA, N.A., AS AGENT | 2019-07-25 | — | — | US | claimed |
| EP-3496951-A1 | SILVER ION CARBOXYLATE N-HETEROAROMATIC COMPLEXES AND USES | Eastman Kodak Company (US) | 2019-06-19 | — | — | EP | claimed |
| WO-2018102125-A1 | SILVER ION ALPHA-OXY CARBOXYLATE-OXIME COMPLEXES FOR PHOTOLITHOGRAPHIC PROCESSES TO GENERATE ELECTRICALLY CONDUCTING METALLIC STRUCTURES | EASTMAN KODAK COMPANY (US) | 2018-06-07 | — | — | WO | claimed |
| US-20180148583-A1 | PHOTOSENSITIVE COMPOSITIONS CONTAINING SILVER ION a-OXY CARBOXYLATE-OXIME COMPLEXES | BANK OF AMERICA, N.A., AS AGENT | 2018-05-31 | — | — | US | claimed |
| US-20180147602-A1 | METHODS OF PROVIDING ELECTRICALLY-CONDUCTIVE SILVER | BANK OF AMERICA, N.A., AS AGENT | 2018-05-31 | — | — | US | claimed |
| US-20180151265-A1 | ARTICLES HAVING SILVER ION a-OXY CARBOXYLATE OXIME COMPLEXES | PAKON, INC. | 2018-05-31 | — | — | US | claimed |
| WO-2018031235-A1 | SILVER ION CARBOXYLATE N-HETEROAROMATIC COMPLEXES AND USES | EASTMAN KODAK COMPANY (US) | 2018-02-15 | — | — | WO | claimed |
| US-20180047476-A1 | PHOTOSENSITIVE REDUCIBLE SILVER ION-CONTAINING COMPOSITIONS | BANK OF AMERICA, N.A., AS AGENT | 2018-02-15 | — | — | US | claimed |
| WO-2018031234-A1 | SILVER ION CARBOXYLATE PRIMARY ALKYLAMINE COMPLEXES | EASTMAN KODAK COMPANY (US) | 2018-02-15 | — | — | WO | claimed |
| US-9809606-B1 | Silver ion carboxylate N-heteroaromatic complexes | EASTMAN KODAK COMPANY (US) | 2017-11-07 | — | — | US | claimed |
| US-9783553-B1 | Silver ion α-oxy carboxylate-oxime complexes | EASTMAN KODAK COMPANY (US) | 2017-10-10 | — | — | US | claimed |
| US-9718842-B1 | Silver ion carboxylate primary alkylamine complexes | EASTMAN KODAK COMPANY (US) | 2017-08-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048479-A1 | PHOTOSENSITIVE COMPOSITIONS CONTAINING SILVER ION A-OXY CARBOXYLATE-OXIME COMPLEXES | PPOX, OGDH, CYBA | ALDH1A1 33/4885TSHR 4476/4885TDP1 2010/4885 |
| US-20180151265-A1 | ARTICLES HAVING SILVER ION a-OXY CARBOXYLATE OXIME COMPLEXES | PPOX, AOC2, OGFOD1 | ALDH1A1 28/4885TSHR 4338/4885TDP1 1103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.